Ultraformer MPT for Skin Laxity in Sydney CBD: Treatment Considerations
Skin laxity can gradually affect the cheeks, jawline, under-chin area and neck. These changes may make the lower face appear heavier or less defined, even when body weight has remained stable.
Ultraformer MPT is a non-surgical focused ultrasound treatment that may be considered for selected concerns involving mild to moderate skin laxity. However, suitability depends on facial anatomy, skin condition and the cause of the concern.
At Sky Beauty Cosmetic Clinic Sydney CBD, a consultation is completed before the treatment area, cartridge depths and number of shots are recommended.
What Causes Facial Skin Laxity?
The skin naturally produces less collagen and elastin with age. Changes to facial fat, muscles, ligaments and bone structure can also influence how the face is supported.
Skin laxity may be affected by:
• Age and genetics • Sun exposure • Skin thickness and elasticity • Weight changes • Smoking • Hormonal changes • Previous cosmetic treatments • Natural facial structure • Lifestyle and general health
The same degree of laxity can look different between patients because facial proportions and tissue distribution vary.
How Does Ultraformer MPT Work?
Ultraformer MPT delivers micro and macro focused ultrasound energy at selected depths beneath the skin. The treatment creates controlled thermal points within targeted tissue while leaving the skin’s surface intact.
Different cartridges may be used at depths such as 1.5 mm, 2.0 mm, 3.0 mm and 4.5 mm for facial treatments. The practitioner selects the cartridges according to the treatment area, tissue thickness and intended treatment depth.
The goal is to support a gradual tissue response rather than create an immediate surgical-style lift.
Which Areas May Be Treated?
Depending on the assessment, treatment may be considered for:
• Lower cheeks • Jawline • Jowl area • Under the chin • Neck • Brow area • Other selected facial areas
Treating the jawline does not always mean treating only the visible edge of the jaw. The lower cheeks and under-chin area may also influence jawline definition and should be assessed together.
Is the Concern Really Skin Laxity?
A less-defined lower face is not always caused by loose skin.
Its appearance may also be influenced by:
• Under-chin fullness • Facial fat distribution • Chin projection • Jaw structure • Muscle activity • Skin quality • Volume loss • Neck anatomy • A combination of these factors
Ultraformer MPT cannot change the underlying bone structure or replace lost facial volume. If skin laxity is not the main concern, another treatment or a combined plan may be more appropriate.
Who May Be Suitable?
Ultraformer MPT may be discussed for adults who have mild to moderate skin laxity and want a non-surgical treatment with limited interruption to their normal routine.
Suitability also depends on:
• General health • Skin condition • Medical history • Previous treatments • Expectations • The size of the treatment area • The amount of laxity present • The practitioner’s clinical assessment
Patients with significant excess skin may not achieve their desired change with a non-surgical procedure.
How Many Shots May Be Needed?
There is no standard shot number that is suitable for everyone.
A smaller area, such as the under-chin region, may require fewer shots than a full-face and neck treatment. The total may also vary according to the cartridges and treatment modes selected.
More shots do not automatically produce a better result. Appropriate placement, depth selection and treatment coverage are important considerations.
During your consultation, ask which areas are included and how the shots will be divided between different cartridges.
What Does the Treatment Feel Like?
Sensation varies between patients and treatment areas. Patients may notice warmth, tingling or brief points of discomfort as the ultrasound energy is delivered. Areas close to the jawbone or around the mouth may feel more sensitive.
Sky Beauty generally offers topical numbing cream and Panadol when appropriate. Injectable anaesthesia is not provided for Ultraformer MPT.
Tell the practitioner if you experience unusual or intense discomfort during the procedure so the treatment can be reassessed.
Is There Any Downtime?
Ultraformer MPT does not normally require surgical downtime, but temporary reactions can occur.
These may include:
• Redness • Swelling • Tenderness • Tingling • Bruising • Temporary altered sensation • Sensitivity when touching the treated area
Less common complications should also be explained during the consultation. Contact the clinic if symptoms are severe, worsening or persist beyond the expected recovery period.
When May Results Become Visible?
Some patients may notice an early change, but the treatment response generally develops gradually. The appearance may continue evolving as the treated tissue responds over the following weeks and months.
Results vary according to:
• Age • Initial degree of laxity • Skin quality • Treatment area • Number and placement of shots • Cartridge selection • Individual tissue response • Lifestyle and ongoing ageing
A specific level of lifting or tightening cannot be guaranteed.
What Should You Discuss Before Treatment?
Before proceeding, ask your practitioner:
• Is skin laxity the main cause of my concern? • Which areas should be treated together? • Which cartridge depths will be used? • How many shots are recommended? • What discomfort should I expect? • What are the possible risks and limitations? • When should I attend a review? • Are other treatment options more suitable? • What is the complete treatment cost?
You should disclose medications, relevant medical conditions, pregnancy or breastfeeding, implanted devices, recent cosmetic procedures and any history of changes in facial sensation.
Ultraformer MPT at Sky Beauty Sydney CBD
Sky Beauty Cosmetic Clinic offers individual Ultraformer MPT consultations at:
Shop 1060A, World Square 644 George Street, Sydney NSW 2000
A consultation allows the practitioner to assess whether skin laxity is contributing to your concern and develop an individual treatment plan. Results and suitability vary between patients.